CONVATEC GRP PL/ADR (OTCMKTS:CNVVY) was downgraded by research analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating in a research report issued to clients and investors on Monday, The Fly reports.
Separately, Sanford C. Bernstein initiated coverage on shares of CONVATEC GRP PL/ADR in a research report on Tuesday, November 12th. They issued an “underperform” rating on the stock.
Shares of CNVVY opened at $10.15 on Monday. CONVATEC GRP PL/ADR has a twelve month low of $6.03 and a twelve month high of $10.78. The firm has a fifty day simple moving average of $9.78 and a two-hundred day simple moving average of $8.44.
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Recommended Story: Book Value Of Equity Per Share – BVPS Explained
Receive News & Ratings for CONVATEC GRP PL/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONVATEC GRP PL/ADR and related companies with MarketBeat.com's FREE daily email newsletter.